ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

LAZ vs FHI // EV/EBITDA & P/E VALUATION

Lazard Inc. (NYSE) VS. Federated Hermes Inc. (NYSE) • 15-METRIC TALLY: LAZ 2 — FHI 10
▲ EV/EBITDA & P/E VALUATION LEADER: FHI
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LAZ VS. FHI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC LAZ FHI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 24.40% 39.80% -15.40 FHI /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 11.4x 8.0x +3.40 FHI /valuation <GO>
Free Cash Flow Yield 12.62% 6.80% +5.82 LAZ /fcf-yield <GO>
Operating Margin 10.30% 28.50% -18.20 FHI /operating-margins <GO>
Net Profit Margin 7.40% 22.40% -15.00 FHI /net-margins <GO>
Revenue Growth (YoY) 1.50% 10.30% -8.80 FHI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 4.83% 2.42% +2.41 LAZ /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 8/9 -2.00 FHI /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 52.5 57.6 -5.10 FHI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.01 1.03 -0.02 FHI /macro-sensitivity <GO>
Forward P/E Multiple 15.2x 10.0x +5.20 FHI /forward-pe <GO>
Enterprise Scale & Market Cap $3.75B $4.37B -$620.8M FHI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR LAZ REV FHI REV LAZ GROSS % FHI GROSS % LAZ FCF FHI FCF
FY 2025 $3.19B $1.80B — — $487.4M $294.6M
FY 2024 $3.14B $1.63B — — $697.3M $342.5M
FY 2023 $2.59B $1.61B — — $48.0M $239.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LAZ // BETA 1.01
FHI // BETA 1.03